Clinical Trial Update: Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter? [NA]

View source ↗

Summary

A completed clinical trial evaluated whether supplemental oxygen (hyperoxia) during pulmonary rehabilitation impacts outcomes in chronic lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Interstitial Lung Disease
• Pulmonary Hypertension

Snippet

Sponsor: Eastern Switzerland University of Applied Sciences | Conditions: Chronic Obstructive Pulmonary Disease, Asthma | NA | Status: COMPLETED